AL-LAD 150 MCG Blotters

PRODUCT DESCRIPTION

Introduction

AL-LAD (6-Allyl-6-nor-lysergic acid diethylamide) is a synthetic psychedelic compound belonging to the lysergamide family, structurally related to LSD. It is commonly found in blotter form, with dosages such as 150 micrograms per blotter, designed for precise administration in research settings. AL-LAD features an allyl substitution on the lysergic acid backbone, differentiating it from LSD and influencing its distinctive psychoactive profile. It is a semisynthetic alkaloid first investigated for its psychedelic properties in the late 20th century.

Chemical Properties and Specifications

2.1 Structural and Molecular Characteristics

• Chemical Formula: C22H27N3O

• Molecular Weight: 349.47 g/mol

• CAS Number: 65527-61-9

• IUPAC Name: (6aR,9R)-N,N-Diethyl-7-(prop-2-en-1-yl)-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide

• Synonyms:

  • AL-LAD

  • 6-Allyl-6-nor-LSD

  • N-Allylnorlysergic acid diethylamide

2.2 Physical Properties and Purity Standards

• Appearance: Pale brown to light brown solid blotters

• Purity: Generally ≥98% for research-grade batches

• Solubility: Slightly soluble in chloroform, ethyl acetate, and methanol

• Storage Recommendations: Store blotters in a cool, dry place protected from light; powders at -20°C under inert atmosphere for extended shelf life

Pharmacological Profile and Mechanism of Action

3.1 Proposed Mechanism of Action

AL-LAD acts primarily as a potent agonist of the 5-HT2A serotonin receptor, responsible for its psychedelic effects. It also exhibits appreciable affinity for dopamine D1 and D2 receptors, with Ki values indicating moderate binding potency. Its interaction with these receptors modulates neurotransmitter release and neuronal signaling pathways, resulting in altered perception, cognition, and mood.

3.2 Research Applications

AL-LAD is utilized in neuropharmacological research to explore lysergamide receptor binding profiles and psychedelic mechanism dynamics. Its use in behavioral pharmacology includes drug discrimination studies and investigation of serotonergic and dopaminergic system modulation. The compound is also studied as part of novel psychedelic analog research focusing on structure-activity relationships.

Comparative Analysis with Related Compounds

4.1 Compare the compound to Compound(s) often compared to

AL-LAD is chemically similar to LSD and other lysergamides such as ETH-LAD and PRO-LAD. Compared to LSD, it exhibits slightly shorter duration (6-8 hours vs. 8-12 hours) with comparable potency. AL-LAD is noted for producing psychedelic effects with subtly different subjective qualities, including softer visuals and altered emotional tone.

4.2 Advantages for Research

Its standardized 150 mcg blotter format allows for precise, repeatable dosing essential in experimental protocols. The compound’s well-documented pharmacology facilitates comparative studies with closely related lysergamides. Its slightly distinct receptor binding influences offer unique insights into psychedelic structure-activity relationships.

Safety and Handling Guidelines

5.1 Laboratory Safety

Handle blotters and powders using gloves and avoid direct skin contact. Use protective eyewear and work in a ventilated space. Minimize inhalation risk when handling powdered forms.

5.2 Disposal and Environmental Considerations

Dispose of residual materials according to chemical waste guidelines. Prevent environmental release and avoid contamination of water sources.

5.3 Regulatory Status

AL-LAD’s legal status varies worldwide; it may be controlled under analog or specific legislation. Researchers are advised to confirm local regulations prior to experimentation or acquisition.

Frequently Asked Questions (FAQs)

1. What is the dose strength of AL-LAD on blotters?
   Commonly available at 150 micrograms per blotter.

2. How does AL-LAD compare with LSD?
   Similar potency but shorter duration and slightly different subjective effects.

3. What receptors does AL-LAD primarily target?
   Primarily 5-HT2A serotonin receptors, also dopamine D1 and D2 receptors.

4. What is the typical duration of AL-LAD effects?
   Approximately 6 to 8 hours.

5. Is AL-LAD regulated legally?
   It varies by jurisdiction; always verify local laws before use.

Conclusion

AL-LAD 150 mcg blotters provide a precise, high-purity lysergamide psychedelic research chemical with well-characterized receptor activity. Their consistent dosing and analytical clarity make them valuable for pharmacological and neurochemical studies, with adherence to lab safety and regulatory compliance essential.